Search research articles
Contact Us
Filters
Showing results (101-110 of 269) with videos related to
Page
of 27
Sort By:
American Heart Journal
|
November 5, 2003
Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS)
Michael G Shlipak, Lily A Chaput, Eric Vittinghoff, et al.
Plos One
|
December 4, 2018
Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study
C Noel Bairey Merz, Marian B Olson, Sheryl F Kelsey, et al.
European Journal of Preventive Cardiology
|
March 5, 2025
Challenges in Achieving LDL Cholesterol Targets and Novel Approaches to Lipid Lowering
Waqas A Malick, Daein Choi, Anne Langsted, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
July 30, 2015
The Association Between Life-Space and Health Care Utilization in Older Adults with Heart Failure
Alexander X Lo, Kellie L Flood, Richard E Kennedy, et al.
Annals of Internal Medicine
|
January 7, 2003
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial
Alka M Kanaya, David Herrington, Eric Vittinghoff, et al.
Annals of Internal Medicine
|
May 18, 2005
Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease
Alka M Kanaya, David Herrington, Eric Vittinghoff, et al.
Journal of Women'S Health (2002)
|
June 10, 2008
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?
Todd M Brown, Dhananjay Vaidya, William J Rogers, et al.
The American Journal of Cardiology
|
November 11, 2008
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)
Colleen Johnson, David D Waters, David A DeMicco, et al.
American Journal of Preventive Medicine
|
January 24, 2019
A National Study of U.S. Emergency Departments: Racial Disparities in Hospitalizations for Heart Failure
Alexander X Lo, John P Donnelly, Raegan W Durant, et al.
Journal of the American College of Cardiology
|
October 24, 2015
Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011
Vera Bittner, Luqin Deng, Robert S Rosenson, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 269) with videos related to
Sort By:
Page
of 27
American Heart Journal
|
November 5, 2003
Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS)
Michael G Shlipak, Lily A Chaput, Eric Vittinghoff, et al.
Plos One
|
December 4, 2018
Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study
C Noel Bairey Merz, Marian B Olson, Sheryl F Kelsey, et al.
European Journal of Preventive Cardiology
|
March 5, 2025
Challenges in Achieving LDL Cholesterol Targets and Novel Approaches to Lipid Lowering
Waqas A Malick, Daein Choi, Anne Langsted, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
July 30, 2015
The Association Between Life-Space and Health Care Utilization in Older Adults with Heart Failure
Alexander X Lo, Kellie L Flood, Richard E Kennedy, et al.
Annals of Internal Medicine
|
January 7, 2003
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial
Alka M Kanaya, David Herrington, Eric Vittinghoff, et al.
Annals of Internal Medicine
|
May 18, 2005
Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease
Alka M Kanaya, David Herrington, Eric Vittinghoff, et al.
Journal of Women'S Health (2002)
|
June 10, 2008
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?
Todd M Brown, Dhananjay Vaidya, William J Rogers, et al.
The American Journal of Cardiology
|
November 11, 2008
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)
Colleen Johnson, David D Waters, David A DeMicco, et al.
American Journal of Preventive Medicine
|
January 24, 2019
A National Study of U.S. Emergency Departments: Racial Disparities in Hospitalizations for Heart Failure
Alexander X Lo, John P Donnelly, Raegan W Durant, et al.
Journal of the American College of Cardiology
|
October 24, 2015
Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011
Vera Bittner, Luqin Deng, Robert S Rosenson, et al.
Page
of 27